Skip to main content

Table 3 Results of subgroup analyses on OS

From: Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review

Variables

HR[95%CI]

Number

I2

Pd

Year > mediana

 Yes

3.65[2.49–5.36]

6

0.00%

0.578

 No

2.44[1.19–4.99]

7

72.90%

0.001

Country

 East Asia

3.39[2.27–5.05]

10

46.50%

0.051

 Non-East Asia

2.10[0.52–8.54]

3

74.50%

0.02

Marker

 Single

2.72[1.48–5.00]

9

66.80%

0.002

 Multiple

3.77[2.62–5.43]

4

0.00%

0.799

Sampling time point

 Pre-op

3.65[2.49–5.36]

6

0.00%

0.578

 Intra/post-op

2.44[1.19–4.99]

7

72.90%

0.001

Patient no. > medianb

 Yes

3.45[2.57–4.65]

6

0.00%

0.801

 No

2.59[1.08–6.22]

7

74.20%

0.001

Detection rate > meanc

 Yes

1.57[0.42–5.79]

4

74.10%

0.009

 No

3.71[2.84–4.85]

9

0.00%

0.796

Quality of study

 Low

4.06[1.64–10.05]

2

0.00%

0.384

 High

2.95[1.87–4.65]

11

61.50%

0.004

Overall

3.07[2.05–4.62]

13

55.70%

0.008

  1. NOTE: aThe median year for OS was 2012
  2. bThe median patient no. for OS was 103
  3. cThe mean detection rate for OS was 38.12%
  4. dTwo-tailed P value of tests for heterogeneity